Suchergebnisse - "Sung, J J Y"

PubPharm (9)

1

Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patients

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Chuang, W. | Jia, J. | Chan, H. | +13

CommentIn: Aliment Pharmacol Ther. 2018 Jun;47(11):1556-1557. - PMID 29878418

2

Capsule endoscopy in acute upper gastrointestinal hemorrhage : a prospective cohort study

enthalten in: Endoscopy | 2013

von Gralnek, I. | Ching, J. | Maza, I. | +9

CommentIn: Endoscopy. 2013 Sep;45(9):775. - PMID 23990491

3

Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C

enthalten in: Hepatology (Baltimore, Md.) | 2011

von Liaw, Y. | Jia, J. | Chan, H. | +14

4

Randomised clinical trial : efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

enthalten in: Alimentary pharmacology & therapeutics | 2011

von Sun, J. | Hou, J. | Xie, Q. | +14

5

Outcomes of adults hospitalised with severe influenza

enthalten in: Thorax | 2010

von Lee, N. | Choi, K. | Chan, P. | +10

6

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

enthalten in: Gut | 2009

von Wong, G. | Wong, V. | Choi, P. | +7

CommentIn: Gut. 2010 Feb;59(2):276-7; author reply 277. - PMID 20176647

7

Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis : A randomized, controlled trial

enthalten in: Hepatology (Baltimore, Md.) | 2008

von Bosch, J. | Thabut, D. | Albillos, A. | +109

8

Intravenous esomeprazole for prevention of peptic ulcer re-bleeding : rationale/design of Peptic Ulcer Bleed study

enthalten in: Alimentary pharmacology & therapeutics | 2008

von Sung, J. | Mössner, J. | Barkun, A. | +7

9

Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China

enthalten in: Gut | 2003

von Zeng, Z. | Hu, P. | Hu, S. | +4

1
[1]